Table 1.
Source, clone, and dilution of antibodies used in this study.
Table 2.
Basal clinicopathologic characteristics of patients with breast cancer metastasis according to metastatic site.
Fig 1.
Expression of lipid metabolism-related proteins in metastatic breast cancer according to metastatic site.
There were significant differences in the expression of lipid metabolism-related proteins according to metastatic site, with the highest expression of acyl-CoA oxidase 1 and FASN in brain metastases.
Table 3.
Expression of metabolism-related proteins in the tumor cell compartment of breast cancer metastases according to metastatic site.
Table 4.
Correlation of expression of metabolism-related proteins between primary and metastatic breast cancer according to metastatic site*.
Fig 2.
Correlation between pathologic factors and expression of lipid metabolism-related proteins.
Fig 3.
The impact of expression of lipid metabolism related proteins in metastatic breast cancer (a, b), liver metastasis (c), lung metastasis (d) and brain metastasis (e, f).
Table 5.
Univariate analysis of the association between expression levels of metabolism-related proteins in metastatic breast cancers and overall survival by the log-rank test.
Table 6.
Multivariate analysis of patient prognoses in metastatic breast cancer.